Terragen Secures 1st Commercial Feedlot, Mort & Co Update
Filed with ASX · · 5 pages · English
Summary by 6ix AI
The agreement includes a minimum order of doses and is contingent upon certain conditions being met, including the installation of a dispensing unit at the feedlot. Additionally, Terragen is involved in a large-scale trial assessing feedlot performance and eating quality, supported by Meat & Livestock Australia and Mort & Co. The trial aims to validate the effectiveness of Terragen's products across a significant number of cattle and is expected to commence soon.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Terragen
- Appendix 4C - 31 March 2026
- Report finds GLP achieves 12% increase in maize silage yield
- Appendix 4D and Half Year Financial Report - 31 Dec 2025
- Terragen Raises $7.0m to Accelerate Global Commercialisation
- Trading Halt
Later from Terragen
- Appendix 4C - 30 June 2026
- 2026 Annual Report to Shareholders
- FY26 Corporate Governance Statement and Appendix 4G
- TGH Appendix 4E and FY26 Annual Report
- Change of Joint Company Secretary
Follow Terragen into a list and get an email when it puts out news.
Follow Terragen